News
News
Academy
Multimedia
Editorial PodcastsEditorial VideosPeer ExchangeProfiles in MedicineShorts
Conferences
Conference CoverageConference Listing
More
Publications
Pharmaceutical Executive
Partner Perspectives
Resources
Content Engagement HubsE-BooksEventsSponsored PodcastsSponsored VideosWebcastsWhitepapers

Subscribe

  • News
  • Academy
  • Multimedia
  • Conferences
  • Publications
  • Partner Perspectives
  • Resources
  • Subscribe
  • Corporate Communications
    • Press Releases
    • Executive Roundtable
    • Executive Profiles
    • Leadership
  • Direct-to-Consumer
    • Patient Education
    • Healthcare Access
    • Telehealth
  • Emerging Biopharma
    • Partnerships
    • Funding
  • IR Licensing and Partnerships
    • Finance
    • Industry Trends
  • Market Access
    • Patient Access
    • Pricing
    • Strategy
  • Medical Affairs
    • Patient Advocacy
    • Clinical Data
    • Pharmacovigilance
  • Operations
    • Sustainability
    • Technology
    • R&D/Clinical Trials
    • Supply Chain
  • Patient Engagement
    • DE&I
  • Regulatory
    • FDA
    • Legal
    • Global
  • Sales & Marketing
    • Sales Effectiveness
    • Campaigns
    • DTC Marketing
    • Medical Education
Spotlight -
Emerging Pharma Leaders Awards|
Latest Executive Roundtables|
Asembia 2025 |
Sales Effectiveness
Advertisement
|Articles|September 22, 2015

Jenna Earl

Author(s)Jenna Earl
Advertisement

Jenna Ealr is Senior Consultant at Blue Latitude

http://bluelatitude.net/about-us-strategic-marketing-consultants/jenna/

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!
Advertisement

Related Content

Advertisement
Pharmaceutical Executive

Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals

ByNicholas Jacobus
March 12th 2026

Agentic AI and the Future of Commercial Excellence in Life Sciences

ByTanveer Nasir,Amber Pahare
March 12th 2026
Stock.adobe.com

Navigating Complexity in Emerging Biotech: Innovations, Integrations, and Initial Hurdles

ByNicholas Jacobus
March 12th 2026
Stock.adobe.com

Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12

ByNicholas Jacobus
March 12th 2026
Pharmaceutical Executive

Moving CAR-T Beyond Oncology

ByMike Hollan,Vincent Hennemand
March 12th 2026
Advertisement
Advertisement

Trending on PharmExec

1

Eli Lilly Releases Open Letter Warning of Potential Safety Risks for Compounded Tirzepatide Plus Vitamin B12

2

Pharmaceutical Executive Daily: Senate Democrats Seeking Information on MFN Pharma Deals

3

Navigating Complexity in Emerging Biotech: Innovations, Integrations, and Initial Hurdles

4

Agentic AI and the Future of Commercial Excellence in Life Sciences

  • About
  • Advertise
  • Contact Us
  • Editorial Board
  • Editorial Submission Guidelines
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us